Federal Register #MA8433233

DEA Registration Applications for Importation and Bulk Manufacturing of Controlled Substances

This opportunity involves the Drug Enforcement Administration (DEA) reviewing applications for registration as importers and bulk manufacturers of controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), Department of Justice - OEMs and Vendors: - Prof Compounding CTS of Ameri (importer) - Galephar Pharmaceutical Research Inc. (importer) - Biopharmaceutical Research Company (bulk manufacturer) - Chattem Chemicals (bulk manufacturer) - Products/Services Requested: - Importation and bulk manufacturing of controlled substances for domestic manufacturing, analytical purposes, and research - Key substances include: - Morphine Sulfate USP (part number 9300) - Hydromorphone (part number 9150) - Morphine (part number 9300) - Marihuana Extract (part number 7350) - Marihuana (part number 7360) - Tetrahydrocannabinols (part number 7370) - Gamma Hydroxybutyric Acid (part number 2010) - 4-Methoxyamphetamine (part number 7411) - Dihydromorphine (part number 9145) - Amphetamine (part number 1100) - Methamphetamine (part number 1105) - Lisdexamfetamine (part number 1205) - Methylphenidate (part number 1724) - Cocaine (part number 9041) - Codeine (part number 9050) - Dihydrocodeine (part number 9120) - Oxycodone (part number 9143) - Ecgonine (part number 9180) - Hydrocodone (part number 9193) - Levorphanol (part number 9220) - Methadone (part number 9250) - Methadone intermediate (part number 9254) - Oripavine (part number 9330) - Thebaine (part number 9333) - Oxymorphone (part number 9652) - Noroxymorphone (part number 9668) - Alfentanil (part number 9737) - Remifentanil (part number 9739) - Sufentanil (part number 9740) - Tapentadol (part number 9780) - Fentanyl (part number 9801) - Unique/Notable Requirements: - Substances are Schedule I and II controlled substances - Purposes include domestic manufacturing, analytical testing, and research - Registration is required for importation and manufacturing - No specific quantities disclosed - Applicants must comply with DEA regulations for handling controlled substances

Description

This notice pertains to a decision and order issued by the Drug Enforcement Administration (DEA) involving Catina Allen, N.P. The DEA proposed revocation of her Certificate of Registration due to her lack of authority to handle controlled substances in Indiana, where she is registered. The order details the expiration of her state licenses and the resulting ineligibility to maintain DEA registration. The DEA has revoked her registration and denied any pending applications for renewal or modification, effective September 24, 2026.

View original listing